Nanomedicine for global health

Nathaniel Tsai; Bryan Lee; Austin Kim; Richard Yang; Ricky Pan; Dong-Keun Lee; Edward K Chow; Dean Ho

doi:10.1177/2211068214538263

Nanomedicine for global health

J Lab Autom. 2014 Dec;19(6):511-6. doi: 10.1177/2211068214538263. Epub 2014 Jun 5.

Authors

Nathaniel Tsai¹, Bryan Lee², Austin Kim¹, Richard Yang¹, Ricky Pan¹, Dong-Keun Lee¹, Edward K Chow³, Dean Ho⁴

Affiliations

¹ Division of Oral Biology and Medicine, UCLA School of Dentistry, Los Angeles, CA, USA.
² Department of Bioengineering, UCLA School of Engineering and Applied Science, Los Angeles, CA, USA.
³ Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
⁴ Division of Oral Biology and Medicine, UCLA School of Dentistry, Los Angeles, CA, USA Department of Bioengineering, UCLA School of Engineering and Applied Science, Los Angeles, CA, USA Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA California NanoSystems Institute, UCLA, Los Angeles, CA, USA csikce@nus.edu.sg dean.ho@ucla.edu.

PMID: 24902713
DOI: 10.1177/2211068214538263

Abstract

Despite modern advances, a broad range of disorders such as cancer and infectious diseases continually afflict the global population. Novel therapeutics are continuously being explored to address these challenges. Therefore, scalable, effective, and safe therapies that are readily accessible to third-world countries are of major interest. In this article, we discuss the potential advantages that the nanomedicine field may harness toward successful implementation against some of the major diseases of our generation.

Keywords: HIV/AIDS; cancer; drug delivery; global health; nanomedicine.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

MeSH terms

Diagnostic Tests, Routine / methods*
Global Health*
Humans
Nanomedicine / methods*
Nanomedicine / trends
Therapeutics / methods*

Grants and funding

U54CA151880/CA/NCI NIH HHS/United States